Array ( [0] => Applebot/0.1 [1] => facebookexternalhit/1.1 [2] => LinkedInBot/1.0 [3] => meta-externalagent/1.1 [4] => Amazonbot/0.1 [5] => BLEXBot/1.0 [6] => DotBot/1.2 [7] => Qwantbot/1.0_1997801 [8] => AhrefsBot/7.0 [9] => DataForSeoBot/1.0 [10] => MatchorySearch/1.3 [11] => WRTNBot/1.0 [12] => Sogou web spider/4.0 [13] => MojeekBot/0.11 [14] => Yeti/1.1 [15] => SeznamBot/4.0 [16] => SemrushBot-SI/0.97 [17] => MistralAI-User/1.0 [18] => Qwantbot/1.0 [19] => coccocbot-web/1.0 [20] => coccocbot-image/1.0 [21] => PlagAwareBot/3.2 [22] => Barkrowler/0.9 [23] => AwarioSmartBot/1.0 [24] => PetalBot [25] => archive.org_bot [26] => Iframely/1.3.1 [27] => LogRocket-AssetCacher [28] => Slackbot 1.0 [29] => node-fetch/1.0 [30] => MJ12bot/v1.4.8 [31] => MJ12bot/v2.0.0 [32] => Timpibot/0.9 [33] => AwarioBot/1.0 [34] => MJ12bot/v2.0.1 [35] => Qwantbot/1.0_2850318 [36] => SiteAuditBot/0.97 [37] => Scrapy/2.11.2 [38] => CCBot/2.0 [39] => MJ12bot/v2.0.2 [40] => Scrapy/2.13.3 [41] => WordPress/6.8.3 [42] => MJ12bot/v2.0.4 [43] => SemrushBot/7~bl [44] => Qwairy-Bot/1.0 [45] => Embedly/0.2 [46] => GeedoProductSearch [47] => SemrushBot [48] => vkShare [49] => inkrich [50] => Discordbot/2.0 [51] => IbouBot/1.0 [52] => trafilatura/1.6.3 [53] => AnsehnBot/1.0 [54] => WP-URLDetails/6.8.3 [55] => HubSpot Crawler [56] => ShapBot/0.1.0 [57] => udu/1.6.5 [58] => aiohttp/3.13.1 [59] => l9scan/2.0 [60] => Trident/5.0 [61] => SmartBotCrawler/1.0 [62] => ) The user agent is not in the allowed list.Array ( [0] => pingbot/2.0 [1] => Googlebot/2.1 [2] => ChatGPT-User/1.0 [3] => PerplexityBot/1.0 [4] => OAI-SearchBot/1.0 [5] => GPTBot/1.2 [6] => Perplexity-User/1.0 [7] => YandexBot/3.0 [8] => YandexFavicons/1.0 [9] => AdsBot-Google-Mobile [10] => AdsBot-Google [11] => Gemini-Deep-Research [12] => DuckAssistBot/1.1 [13] => DuckDuckBot/1.1 [14] => GoogleOther [15] => YandexRenderResourcesBot/1.0 [16] => YandexImages/3.0 [17] => DuckAssistBot/1.2 [18] => Baiduspider/2.0 [19] => Baiduspider-render/2.0 [20] => bingbot/2.0 [21] => YandexUserproxy [22] => Pingdom.com_bot_version_1.4_ [23] => GPTBot/1.3 [24] => PingdomPageSpeed/1.0 [25] => YandexMobileBot/3.0 [26] => OAI-SearchBot/1.3 [27] => ClaudeBot/1.0 [28] => OAI-SearchBot/1.3 [29] => ) The user agent is an allowed/known agent.
Ambulatory Blood Pressure Monitoring Devices Market Size & Growth Forecast 2026–2035, By Segments (End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Base Year Value (2025)
USD 1.52 Billion
CAGR (2026-2035)
11.6%
Forecast Year Value (2035)
USD 4.55 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035
Ambulatory Blood Pressure Monitoring Devices Market Intelligence Snapshot:
-
Regional Market Dynamics:
- North America leads with 41.98% share, driven by routine hypertension screening, outpatient diagnostic integration, chronic disease management reliance, and mature device distribution supporting consistent ambulatory monitoring adoption.
- Asia Pacific is growing at 12.99% CAGR as healthcare infrastructure improves, access expands, and outpatient monitoring adoption increases across hospitals managing rising cardiovascular patient volumes.
-
Segment Momentum:
- Hospitals accounted for 62.86% of the market in 2025 due to their central role in diagnosing complex hypertension cases and managing monitoring, interpretation, and follow-up within established clinical workflows.
- Homecare is growing fastest as patients increasingly prefer convenient monitoring outside healthcare facilities, supporting routine hypertension follow-up while reducing repeat visits and improving comfort during extended monitoring periods.
-
Market Expansion Drivers:
- Rising global hypertension prevalence increasing demand for continuous blood pressure monitoring solutions.
- Expanding geriatric population accelerating adoption of ambulatory cardiovascular monitoring devices.
- Advancements in digital and mobile-connected ABPM devices improving remote patient monitoring capabilities.
-
Leading Market Participants:
Major companies in the ambulatory blood pressure monitoring devices market include Omron Corporation (Japan), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Spacelabs Healthcare, Inc. (United States), SunTech Medical, Inc. (United States), A&D Company, Limited (Japan), Microlife Corporation (Taiwan), Schiller AG (Switzerland), Hillrom Holdings, Inc. (United States), Withings (France).
Global Market Forecast Snapshot:
-
Market Outlook:
- 2025 Market Size: USD 1.52 Billion
- 2026 Market Size: USD 15.2 billion
- Projected Market Size: USD 4.55 Billion by 2035
- Growth Forecasts: 11.6% CAGR (2026-2035)
-
Regional and Segment Outlook:
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Ambulatory Blood Pressure Monitors (Product)
- Emerging Opportunity Segment: Homecare (End-use) | Ambulatory Blood Pressure Monitors (Product)
Market Growth Drivers and Industry Trends
Rising global hypertension prevalence increasing demand for continuous blood pressure monitoring solutionsAs hypertension becomes more widespread, clinicians are relying less on isolated clinic readings and more on data that captures blood pressure variation over a full day and night, which is directly strengthening demand in the ambulatory blood pressure monitoring devices market. This trend is especially pronounced where masked hypertension, white-coat effects, and treatment-resistant cases complicate diagnosis or medication adjustment, making continuous monitoring a practical tool for more confident clinical decisions. In practice, higher patient volumes tied to hypertension screening and long-term management increase device utilization by hospitals, cardiology practices, and outpatient centers, reinforcing replacement cycles and procurement activity in the ambulatory blood pressure monitoring devices market.
Expanding geriatric population accelerating adoption of ambulatory cardiovascular monitoring devices
An aging population is increasing the number of patients with fluctuating blood pressure, multiple comorbidities, and complex medication regimens, all of which make ambulatory assessment more clinically useful than periodic office checks. In the ambulatory blood pressure monitoring devices market, this translates into stronger adoption by providers managing elderly patients who require closer observation for nocturnal hypertension, orthostatic changes, and therapy response without repeated in-person visits. The result is a more routine role for ABPM in chronic disease management pathways, aiding market expansion through greater integration into outpatient cardiovascular care and senior-focused health services.
Advancements in digital and mobile-connected ABPM devices improving remote patient monitoring capabilities
Digital and mobile-connected product development is changing purchasing priorities in the ambulatory blood pressure monitoring devices market by making device data easier to transmit, review, and incorporate into remote care workflows. Providers increasingly favor ABPM systems that reduce manual data handling, support faster interpretation, and enable follow-up decisions without requiring patients to return solely for data retrieval, which improves operational efficiency as remote monitoring models expand. These capabilities also influence market adoption by aligning ABPM devices with broader digital health infrastructure, encouraging healthcare organizations to upgrade from basic standalone units to connected platforms that fit telehealth and longitudinal patient management strategies.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global hypertension prevalence increasing demand for continuous blood pressure monitoring solutions | 2.40% | High | North America, Asia Pacific, Africa | High | Near Term |
| Expanding geriatric population accelerating adoption of ambulatory cardiovascular monitoring devices | 2.10% | Moderate | Europe, North America, Asia Pacific | High | Mid Term |
| Advancements in digital and mobile-connected ABPM devices improving remote patient monitoring capabilities | 1.70% | Moderate | North America, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!
Regional Demand Dynamics
Largest Region
North America
41.98% Market Share in 2025
North America held a 41.98% share of the ambulatory blood pressure monitoring devices market in 2025, bolstered by established hypertension screening and follow-up practices, broad access to outpatient diagnostics, and routine use of evidence-based monitoring across physician offices and specialty care settings. Demand is reinforced by a care model that increasingly relies on out-of-clinic blood pressure measurement to confirm suspected hypertension, assess treatment response, and reduce the risk of misclassification from single-point readings. This practical integration into chronic disease management, together with a mature medical device distribution environment, helps sustain the region’s leading position.
Asia Pacific is projected to expand at a 12.99% CAGR over the forecast period in the ambulatory blood pressure monitoring devices market, fueled by rising adoption of structured blood pressure monitoring as healthcare systems manage a larger volume of patients requiring ongoing cardiovascular assessment. Growth is being accelerated by improving access to diagnostic services, expanding healthcare infrastructure, and wider use of monitoring devices in urban hospitals and ambulatory care settings where clinicians need more reliable real-world blood pressure data. As care delivery becomes more prevention-oriented and outpatient monitoring gains traction, regional uptake is strengthening across both established and developing healthcare markets.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Nascent | Nascent |
| Cost-Sensitive Region | Medium | High | Medium | High | High |
| Regulatory Environment | Supportive | Neutral | Restrictive | Neutral | Restrictive |
| Demand Drivers | Strong | Moderate | Strong | Weak | Weak |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | High | Medium | High | Low | Low |
| New Entrants / Startups | Moderate | Sparse | Moderate | Sparse | Sparse |
| Macro Indicators | Strong | Stable | Stable | Weak | Weak |
Key Country Insights
The U.S. ambulatory blood pressure monitoring devices market benefits from expanding remote patient monitoring programs and wider adoption of digital healthcare solutions. Healthcare providers across the U.S. increasingly incorporate ambulatory monitoring into hypertension management to improve diagnostic accuracy and long-term patient follow-up.
Japan increasingly deploys ambulatory blood pressure monitoring devices to support hypertension management among its aging population. Healthcare providers in Japan emphasize reliable long-duration monitoring solutions that enable early intervention and more personalized cardiovascular treatment decisions.
South Korea integrates ambulatory blood pressure monitoring devices with connected healthcare platforms and digital patient management initiatives. Medical providers in South Korea continue adopting compact monitoring systems that improve workflow efficiency and facilitate data-driven clinical decision-making.
Germany prioritizes ambulatory blood pressure monitoring devices that support evidence-based cardiovascular care and standardized clinical workflows. Healthcare institutions in Germany continue integrating validated monitoring technologies with digital health systems to improve diagnostic efficiency and patient management.
France emphasizes ambulatory blood pressure monitoring as part of preventive cardiovascular care and routine hypertension assessment. Hospitals and outpatient clinics across France continue expanding the use of validated monitoring devices to enhance diagnosis and optimize treatment planning.
Italy continues strengthening outpatient cardiovascular diagnostics through broader adoption of ambulatory blood pressure monitoring devices. Healthcare facilities in Italy increasingly value user-friendly systems that improve patient comfort while delivering accurate blood pressure measurements over extended monitoring periods.
Segment Leadership and Growth Trends
Hospitals held a 62.86% share of the ambulatory blood pressure monitoring devices market in 2025, reflecting their central role in diagnosing complex hypertension patterns and managing patients who require structured clinical evaluation. This leadership is maintained through the routine use of ambulatory monitoring in hospital-led cardiology and internal medicine workflows, where device selection, fitting, interpretation, and follow-up can be handled within established care pathways. The hospital setting also supports broader use among patients with comorbidities or unclear blood pressure variability, which helps preserve segment share in the ambulatory blood pressure monitoring devices market.
Homecare is emerging as the fastest-growing end-use segment in the ambulatory blood pressure monitoring devices market as blood pressure assessment increasingly shifts toward more convenient and patient-centered monitoring outside institutional settings. Growth is being reinforced through rising preference for at-home diagnostic support that reduces repeat facility visits while still enabling extended monitoring over daily routines and sleep cycles. Compared with hospital-based use, homecare gains momentum because it aligns more directly with ongoing management needs, patient comfort, and practical adoption in routine hypertension follow-up.
Product Segment Analysis: Ambulatory Blood Pressure Monitors (Largest & Fastest-Growing Segment)
Ambulatory Blood Pressure Monitors accounted for a 63.54% share of the ambulatory blood pressure monitoring devices market in 2025, and the segment continues to expand because it represents the core product used for continuous blood pressure tracking across real-world daily activity. Its market leadership is rooted in direct clinical utility, as these devices are the primary tool for capturing fluctuations that conventional point measurements may miss. The same practical advantage is also driving continued growth in the ambulatory blood pressure monitoring devices market, as healthcare providers and patients increasingly rely on longer-duration monitoring to support more accurate diagnosis and follow-up.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| End-use | Hospitals, Ambulatory Surgical Centers & Clinics, Homecare | Hospitals | Homecare |
| Product | Ambulatory Blood Pressure Monitors, Instrument & Accessories, Blood Pressure Cuffs, Others | Ambulatory Blood Pressure Monitors | Ambulatory Blood Pressure Monitors |
Read our Research ApproachCompetitive Landscape and Market Positioning
Company Profile
Business Overview Financial Highlights Product Landscape SWOT Analysis Recent Developments Company Heat Map Analysis
1. Omron Corporation (Japan)
2. Koninklijke Philips N.V. (Netherlands)
3. GE HealthCare Technologies Inc. (United States)
4. Spacelabs Healthcare Inc. (United States)
5. SunTech Medical Inc. (United States)
6. A&D Company Limited (Japan)
7. Microlife Corporation (Taiwan)
8. Schiller AG (Switzerland)
9. Hillrom Holdings Inc. (United States)
10. Withings (France)
The ambulatory blood pressure monitoring devices market is advancing through the development of more accurate, portable, and user-friendly monitoring systems designed to improve long-term cardiovascular assessment. Integration of digital health technologies and wireless connectivity features is enabling better remote monitoring and data accessibility for healthcare professionals. Growing emphasis on preventive healthcare and continuous patient monitoring is further supporting innovation across the ambulatory blood pressure monitoring devices market.
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Sky Labs | May-26 | The "CART BP pro" ring-type cuffless blood pressure monitor became the world’s first of its kind to be integrated into the 2026 Korean Society of Hypertension Guidelines. By utilizing AI-powered photoplethysmography, the device allows for 24-hour monitoring without the discomfort of inflatable cuffs, providing a clinically validated alternative for tracking nocturnal and resistant hypertension. |
| OMRON Healthcare | Dec-25 | OMRON Healthcare unveiled a global ECG strategy aimed at integrating home-based cardiovascular monitoring with hospital care. This initiative includes expanding the "KeeboHealth" platform—which links ECG-enabled blood pressure monitors with AI-based interpretation services—to provide continuous, data-driven management for patients at risk of heart failure. |
| Aktiia SA | Jul-25 | Aktiia received FDA clearance for its "Hilo Band," marking the first time a cuffless blood pressure monitor has been approved for over-the-counter use in the United States. The wrist-worn device utilizes light-based sensors to provide 24-hour automated monitoring, significantly improving patient compliance and comfort compared to traditional, inflatable cuff-based ambulatory systems. |
| ASUSTeK Computer | Apr-25 | ASUSTeK launched the "VivoWatch 6 AERO" smart band, integrating cuffless blood pressure and ECG measurement via advanced fingertip sensors. This development highlights the market trend of incorporating medical-grade diagnostic capabilities into consumer-friendly, lightweight wearable technology for real-time health tracking and AI-driven insights. |
| Myant Inc. | Jan-25 | Myant Inc. acquired mmHg Inc. to bolster its remote care portfolio. By integrating mmHg’s cardiovascular monitoring platform into its existing AI-enabled solutions, Myant aims to enhance the delivery of personalized, medical-grade remote health monitoring for chronic condition management, including hypertension detection and long-term blood pressure tracking. |
Frequently Asked Questions
What is the current revenue of the ambulatory blood pressure monitoring devices market?
The market revenue for ambulatory blood pressure monitoring devices is anticipated at USD 1.68 billion in 2026.
How much is the ambulatory blood pressure monitoring devices industry expected to grow by 2035?
Ambulatory Blood Pressure Monitoring Devices Market size is projected to expand significantly moving from USD 1.52 billion in 2025 to USD 4.55 billion by 2035 with a CAGR of 11.6% during the 2026-2035 forecast period.
How is rising hypertension prevalence influencing procurement strategies in the ambulatory blood pressure monitoring devices market?
Growing hypertension cases are increasing demand for continuous blood pressure assessment, prompting hospitals, cardiology practices, and outpatient centers to expand ABPM procurement for improved diagnosis, long-term management, and higher device utilization across routine care pathways.
Why are connected ABPM devices becoming a strategic investment priority for healthcare providers?
Mobile-connected ABPM systems improve remote monitoring by simplifying data transmission, reducing manual workflows, and supporting telehealth integration, encouraging healthcare organizations to replace standalone devices with digitally connected platforms for more efficient longitudinal patient management.
Why do hospitals lead the ambulatory blood pressure monitoring devices market?
Hospitals accounted for 62.86% of the market in 2025 due to their central role in diagnosing complex hypertension cases and managing monitoring, interpretation, and follow-up within established clinical workflows.
Why is homecare becoming the fastest-growing end-use segment in the ambulatory blood pressure monitoring devices market?
Homecare is growing fastest as patients increasingly prefer convenient monitoring outside healthcare facilities, supporting routine hypertension follow-up while reducing repeat visits and improving comfort during extended monitoring periods.
Why does North America lead the ambulatory blood pressure monitoring devices market?
North America leads with 41.98% share, driven by routine hypertension screening, outpatient diagnostic integration, chronic disease management reliance, and mature device distribution supporting consistent ambulatory monitoring adoption.
How is Asia Pacific driving growth in this market?
Asia Pacific is growing at 12.99% CAGR as healthcare infrastructure improves, access expands, and outpatient monitoring adoption increases across hospitals managing rising cardiovascular patient volumes.
Which companies are driving growth in the ambulatory blood pressure monitoring devices landscape?
Major companies in the ambulatory blood pressure monitoring devices market include Omron Corporation (Japan), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Spacelabs Healthcare, Inc. (United States), SunTech Medical, Inc. (United States), A&D Company, Limited (Japan), Microlife Corporation (Taiwan), Schiller AG (Switzerland), Hillrom Holdings, Inc. (United States), Withings (France).
Our Clients
Why Choose Us
Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.
Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.
Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.
Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.
Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.
Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.
Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.
Select Licence Type
